The effect of varenicline on mood and cognition in smokers with HIV
Sign Up to like & getrecommendations! Published in 2020 at "Psychopharmacology"
DOI: 10.1007/s00213-020-05451-w
Abstract: Rationale Barriers to smoking cessation, including negative affect and cognitive dysfunction, may contribute to high smoking rates among people living with HIV/AIDS (PLWH). Varenicline may help PLWH quit smoking by improving mood and cognition, yet… read more here.
Keywords: varenicline mood; varenicline; effect varenicline; mood cognition ... See more keywords
Effect of varenicline on behavioral deficits in a rat model of Parkinson’s disease induced by unilateral 6-hydroxydopamine lesion of substantia nigra
Sign Up to like & getrecommendations! Published in 2018 at "Behavioural Pharmacology"
DOI: 10.1097/fbp.0000000000000355
Abstract: Nicotinic acetylcholine receptors (nAChRs) are implicated in the pathogenesis of Parkinson’s disease (PD). Varenicline tartrate is a partial agonist at &agr;4&bgr;2 and full agonist at &agr;7 neuronal nAChR subunits. A unilateral lesion of the substantia… read more here.
Keywords: lesion substantia; behavioral deficits; substantia nigra; effect varenicline ... See more keywords
Effect of Varenicline on Tardive Dyskinesia: A Pilot Study
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Psychopharmacology and Neuroscience"
DOI: 10.9758/cpn.2021.19.2.355
Abstract: Objective Although evidence implicates striatal cholinergic impairment as a mechanism underlying tardive dyskinesia, trials of nonspecific cholinergic agents have been inconclusive. As a partial agonist at specific nicotinic receptor subtypes, varenicline reduces drug-induced dyskinesias in… read more here.
Keywords: effect varenicline; dyskinesia; tardive dyskinesia; varenicline tardive ... See more keywords